Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.2 USD -2.14% Market Closed
Updated: May 19, 2024
MREO
/
Cash Flow Statement
/
Capital Expenditures

Mereo Biopharma Group PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Capital Expenditures Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Capital Expenditures
-£10k
CAGR 3-Years
21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Capital Expenditures
-$169k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Capital Expenditures
-$11m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Capital Expenditures
-$841k
CAGR 3-Years
18%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Capital Expenditures
-£5.4m
CAGR 3-Years
-21%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Capital Expenditures
-£34.6m
CAGR 3-Years
-12%
CAGR 5-Years
-3%
CAGR 10-Years
-15%

See Also

What is Mereo Biopharma Group PLC's Capital Expenditures?
Capital Expenditures
-10k GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Capital Expenditures amounts to -10k GBP.

What is Mereo Biopharma Group PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
21%

Over the last year, the Capital Expenditures growth was 98%. The average annual Capital Expenditures growth rates for Mereo Biopharma Group PLC have been 21% over the past three years .

ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.